Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019

BACKGROUND: The national policy for malaria treatment of the Democratic Republic of Congo recommends two first-line artemisinin-based combinations for the treatment of uncomplicated malaria: artesunate-amodiaquine and artemether-lumefantrine. This study investigated the presence of markers associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Yobi, Doudou M., Kayiba, Nadine K., Mvumbi, Dieudonné M., Boreux, Raphael, Kabututu, Pius Z., Situakibanza, Hippolyte N. T., Umesumbu, Solange E., De Mol, Patrick, Speybroeck, Niko, Mvumbi, Georges L., Hayette, Marie-Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953712/
https://www.ncbi.nlm.nih.gov/pubmed/33706773
http://dx.doi.org/10.1186/s12936-021-03636-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953712/
https://www.ncbi.nlm.nih.gov/pubmed/33706773
http://dx.doi.org/10.1186/s12936-021-03636-y

Ejemplares similares